Gamifant Interactions
There are 188 drugs known to interact with Gamifant (emapalumab), along with 2 disease interactions. Of the total drug interactions, 25 are major, and 163 are moderate.
- View all 188 medications that may interact with Gamifant
- View Gamifant disease interactions (2)
Most frequently checked interactions
View interaction reports for Gamifant (emapalumab) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adriamycin RDF (doxorubicin)
- Advate (antihemophilic factor)
- Adzenys XR-ODT (amphetamine)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alhemo (concizumab)
- Alimta (pemetrexed)
- Alphanate (antihemophilic factor/von willebrand factor)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amlodipine / hydrochlorothiazide / olmesartan
- Amondys 45 (casimersen)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Baraclude (entecavir)
- Feiba (anti-inhibitor coagulant complex)
- Humira (adalimumab)
- Spinraza (nusinersen)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Sustiva (efavirenz)
- Tibsovo (ivosidenib)
- Valcyte (valganciclovir)
- Valium (diazepam)
- Vitrakvi (larotrectinib)
- Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
- Zejula (niraparib)
Gamifant disease interactions
There are 2 disease interactions with Gamifant (emapalumab) which include:
Report options
QR code containing a link to this page
More about Gamifant (emapalumab)
- Gamifant consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
